If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

The world's largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt ...

Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, ...

PITTSBURGH (KFSN) -- As many as one million Americans are living with Parkinson's disease, a progressive movement disorder with no cure. Medications may help control the symptoms for a period of time, ...

Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled ...

A cough medicine used for decades in Europe called ambroxol has shown promise for treating dementia in people with Parkinson's disease. The corresponding study was published in JAMA Neurology. People ...

The Parkinson’s Foundation announced July 16 the launch of a nationwide initiative providing free genetic testing for clinically relevant, Parkinson’s disease-related genes, the results of which will ...

A Northwestern Medicine research lab has found a usually harmless virus in brain samples from Parkinson’s patients. The idea that Parkinson’s could be linked to a virus had been theorized for years, ...

"I remember my right hand being able to move with much more ease once the stimulation was applied, and this in turn improved ...

Meanwhile, beta blocker medications tend to reduce REM sleep, which is when most dreaming occurs, but research has found that ...